Synaptic Protection in the Brain of WldS Mice Occurs Independently of Age but Is Sensitive to Gene-Dose
Open Access
- 29 November 2010
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 5 (11) , e15108
Abstract
Disruption of synaptic connectivity is a significant early event in many neurodegenerative conditions affecting the aging CNS, including Alzheimer's disease and Parkinson's disease. Therapeutic approaches that protect synapses from degeneration in the aging brain offer the potential to slow or halt the progression of such conditions. A range of animal models expressing the slow Wallerian Degeneration (WldS) gene show robust neuroprotection of synapses and axons from a wide variety of traumatic and genetic neurodegenerative stimuli in both the central and peripheral nervous systems, raising that possibility that WldS may be useful as a neuroprotective agent in diseases with synaptic pathology. However, previous studies of neuromuscular junctions revealed significant negative effects of increasing age and positive effects of gene-dose on WldS-mediated synaptic protection in the peripheral nervous system, raising doubts as to whether WldS is capable of directly conferring synapse protection in the aging brain. We examined the influence of age and gene-dose on synaptic protection in the brain of mice expressing the WldS gene using an established cortical lesion model to induce synaptic degeneration in the striatum. Synaptic protection was found to be sensitive to WldS gene-dose, with heterozygous WldS mice showing approximately half the level of protection observed in homozygous WldS mice. Increasing age had no influence on levels of synaptic protection. In contrast to previous findings in the periphery, synapses in the brain of old WldS mice were just as strongly protected as those in young mice. Our study demonstrates that WldS-mediated synaptic protection in the CNS occurs independently of age, but is sensitive to gene dose. This suggests that the WldS gene, and in particular its downstream endogenous effector pathways, may be potentially useful therapeutic agents for conferring synaptic protection in the aging brain.Keywords
This publication has 52 references indexed in Scilit:
- SMN deficiency disrupts brain development in a mouse model of severe spinal muscular atrophyHuman Molecular Genetics, 2010
- Expression of the neuroprotective slow Wallerian degeneration (Wld S ) gene in non-neuronal tissuesBMC Neuroscience, 2009
- Nicotinamide Mononucleotide Adenylyltransferase Expression in Mitochondrial Matrix Delays Wallerian DegenerationJournal of Neuroscience, 2009
- Non-Nuclear WldSDetermines Its Neuroprotective Efficacy for Axons and SynapsesIn VivoJournal of Neuroscience, 2009
- The WldS gene delays axonal but not somatic degeneration in a rat glaucoma modelEuropean Journal of Neuroscience, 2008
- The Drosophila Cell Corpse Engulfment Receptor Draper Mediates Glial Clearance of Severed AxonsNeuron, 2006
- Delayed synaptic degeneration in the CNS of Wlds mice after cortical lesionBrain, 2006
- A rat model of slow Wallerian degeneration (WldS) with improved preservation of neuromuscular synapsesEuropean Journal of Neuroscience, 2005
- Inhibiting Axon Degeneration and Synapse Loss Attenuates Apoptosis and Disease Progression in a Mouse Model of Motoneuron DiseaseCurrent Biology, 2003
- Absence of Wallerian Degeneration does not Hinder Regeneration in Peripheral NerveEuropean Journal of Neuroscience, 1989